HERLYSTIC trademark application for HER2 cancer treatment
Summary
The USPTO received trademark application TM99431686 for HERLYSTIC, filed October 7, 2025, covering pharmaceutical preparations targeting the HER2 protein for cancer treatment. The application is filed as Intent-to-Use, indicating the applicant plans to commercialize the mark in the future. This is an informational notice of a trademark filing in Class 005 (pharmaceuticals).
What changed
The USPTO published notice of trademark application TM99431686 for HERLYSTIC, covering pharmaceutical preparations targeting HER2 protein for cancer treatment, immunotherapy pharmaceutical preparations, and vaccine preparations targeting HER2 protein for cancer treatment. The application was filed on October 7, 2025, under Intent-to-Use basis.\n\nPharmaceutical companies developing HER2-targeted therapies should review this application to assess potential conflicts with their existing or planned product branding. Trademark applications in Class 005 may affect future product naming decisions in the oncology space. No immediate compliance action is required; this is an informational filing.
Archived snapshot
Mar 31, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
HERLYSTIC
Intent to Use TM99431686 Kind: intenttouse Mar 30, 2026
Abstract
Pharmaceutical preparations targeting the HER2 protein for the treatment of cancer; Immunotherapy pharmaceutical preparations targeting the HER2 protein for the treatment of cancer; vaccine preparations targeting the HER2 protein for the treatment of cancer
Filing Date
2025-10-07
Related changes
Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.